首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

1547698

全球醫院獲得性疾病檢測市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Hospital Acquired Disease Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2032 年，全球醫院獲得性疾病檢測市場的市場規模將從 2023 年的 200 萬美元達到近 200 萬美元，2024-2032 年研究期間複合年成長率為 15.13%。

醫院獲得性疾病檢測涉及診斷醫療機構中因微生物感染或毒素而感染的疾病。重症監護室是醫院中最常見的場所，任何人都可能患病，從而增加發病率、死亡率和醫院費用。最常見的檢驗疾病包括手術部位感染、胃腸炎、肺炎、腦膜炎和泌尿道感染。這些疾病的主要原因是手、導管、呼吸器等醫療器材不乾淨，以及抗生素的過量或不當使用。這些疾病的檢測僅透過視覺和症狀進行診斷，可在入院 48 小時內、出院後 3 天或手術後 30 天內進行。

市場動態

醫療機構衛生條件差和抗藥性微生物的出現將成為該市場成長的重要刺激因素。老年人口的增加和在醫療機構接受慢性病治療的患者發病率的上升將促進該市場的成長。醫療保健行業的技術進步以及新穎的診斷技術和工具將有利於該市場的成長。更好的監測文化來檢測定植患者中看不見的病原體並防止感染傳播將是市場的助推器。缺乏預算、熟練勞動力和嚴格的政府法規將成為不利於市場成長的一些障礙。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球醫院獲得性疾病檢測市場的各個細分市場進行了包容性評估。醫院獲得性疾病檢測行業的成長和趨勢為這項研究提供了整體方法。

市場區隔

醫院獲得性疾病檢測市場報告的這一部分提供了有關國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按測試類型

泌尿道
手術部位
肺炎
血流
抗甲氧西林金黃色葡萄球菌
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲醫院獲得性疾病檢測市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。醫院獲得性疾病檢測市場的主要參與者包括 Abbott Laboratories、Alere Inc、Becton、Dickinson And Company、BioMeRieux SA F、Hoffmann-La Roche Ltd、Hologic Inc、Siemens Healthcare、Diatherix Laboratories Inc.、Meridian Bioscience Inc.、ThermFisher Scientific Inc. 本部分包含競爭格局的整體視圖，其中包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概覽、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 7 章：醫院獲得性疾病檢測公司的競爭格局

醫院獲得性疾病檢測市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 8 章：公司簡介

頂級公司市佔率分析
市場集中度
Abbott Laboratories

公司概況
公司收入
產品
最新動態

Alere Inc

公司概況
公司收入
產品
最新動態

Becton

公司概況
公司收入
產品
最新動態

Dickinson And Company

公司概況
公司收入
產品
最新動態

BioMeRieux SA F

公司概況
公司收入
產品
最新動態

Hoffmann-La Roche Ltd

公司概況
公司收入
產品
最新動態

Hologic Inc

公司概況
公司收入
產品
最新動態

Siemens Healthcare

公司概況
公司收入
產品
最新動態

Diatherix Laboratories Inc.

公司概況
公司收入
產品
最新動態

Meridian Bioscience Inc.

公司概況
公司收入
產品
最新動態

ThermFisher Scientific Inc

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11213861

The global demand for Hospital Acquired Disease Testing Market is presumed to reach the market size of nearly USD XX.X Million by 2032 from USD XX.X Million in 2023 with a CAGR of 15.13% under the study period 2024-2032.

Hospital-acquired disease testing involves the diagnosis of diseases contracted from microbial infections or toxins in a healthcare facility. The intensive care unit is the most common location in a hospital where anyone can contract an illness, increasing morbidity, mortality, and hospital costs. The most common diseases tested include surgical site infections, gastroenteritis, pneumonia, meningitis, and urinary tract infections. The primary cause of these diseases is unclean hands, medical instruments such as catheters, respiratory machines, and excessive or improper use of antibiotics. The testing for these diseases involves diagnosis by sight and symptoms alone and can appear within 48 hours of admission, three days after discharge, or 30 days after an operation.

MARKET DYNAMICS

Lack of poor hygiene and the emergence of drug-resistant organisms in healthcare facilities will be the vital stimulating agents for this market's growth. Increasing the geriatric population and inflating morbidity rates among patients undergoing treatment for chronic diseases in a healthcare facility will boost this market's growth. Technological advancements in the healthcare industry and novel diagnostic techniques and tools will benefit this market's growth. Better surveillance cultures to detect unseen pathogens in colonized patients and prevent transmission of infections will be a market booster. The lack of budget, skilled labor and stringent government regulations will be a few hindrances not favorable to market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Hospital Acquired Disease Testing. The growth and trends of Hospital Acquired Disease Testing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Hospital Acquired Disease Testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Test Type

Urinary Tract
Surgical Site
Pneumonia
Bloodstream
MRSA
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Hospital Acquired Disease Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Hospital Acquired Disease Testing market include Abbott Laboratories, Alere Inc, Becton, Dickinson And Company, BioMeRieux SA F, Hoffmann-La Roche Ltd, Hologic Inc, Siemens Healthcare, Diatherix Laboratories Inc., Meridian Bioscience Inc., ThermFisher Scientific Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. HOSPITAL ACQUIRED DISEASE TESTING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Test Type
- 3.7.2 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET ANALYSIS BY TEST TYPE

5.1. Overview By Test Type
5.2. Historical and Forecast Data
5.3. Analysis By Test Type
5.4. Urinary Tract Historic and Forecast Sales By Regions
5.5. Surgical Site Historic and Forecast Sales By Regions
5.6. Pneumonia Historic and Forecast Sales By Regions
5.7. Bloodstream Historic and Forecast Sales By Regions
5.8. MRSA Historic and Forecast Sales By Regions
5.9. Others Historic and Forecast Sales By Regions

6. GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET ANALYSIS BY GEOGRAPHY

6.1. Regional Outlook
6.2. Introduction
6.3. North America Sales Analysis
- 6.3.1 Overview, Historic and Forecast Data Sales Analysis
- 6.3.2 North America By Segment Sales Analysis
- 6.3.3 North America By Country Sales Analysis
- 6.3.4 United States Sales Analysis
- 6.3.5 Canada Sales Analysis
- 6.3.6 Mexico Sales Analysis
6.4. Europe Sales Analysis
- 6.4.1 Overview, Historic and Forecast Data Sales Analysis
- 6.4.2 Europe By Segment Sales Analysis
- 6.4.3 Europe By Country Sales Analysis
- 6.4.4 United Kingdom Sales Analysis
- 6.4.5 France Sales Analysis
- 6.4.6 Germany Sales Analysis
- 6.4.7 Italy Sales Analysis
- 6.4.8 Russia Sales Analysis
- 6.4.9 Rest Of Europe Sales Analysis
6.5. Asia Pacific Sales Analysis
- 6.5.1 Overview, Historic and Forecast Data Sales Analysis
- 6.5.2 Asia Pacific By Segment Sales Analysis
- 6.5.3 Asia Pacific By Country Sales Analysis
- 6.5.4 China Sales Analysis
- 6.5.5 India Sales Analysis
- 6.5.6 Japan Sales Analysis
- 6.5.7 South Korea Sales Analysis
- 6.5.8 Australia Sales Analysis
- 6.5.9 South East Asia Sales Analysis
- 6.5.10 Rest Of Asia Pacific Sales Analysis
6.6. Latin America Sales Analysis
- 6.6.1 Overview, Historic and Forecast Data Sales Analysis
- 6.6.2 Latin America By Segment Sales Analysis
- 6.6.3 Latin America By Country Sales Analysis
- 6.6.4 Brazil Sales Analysis
- 6.6.5 Argentina Sales Analysis
- 6.6.6 Peru Sales Analysis
- 6.6.7 Chile Sales Analysis
- 6.6.8 Rest of Latin America Sales Analysis
6.7. Middle East & Africa Sales Analysis
- 6.7.1 Overview, Historic and Forecast Data Sales Analysis
- 6.7.2 Middle East & Africa By Segment Sales Analysis
- 6.7.3 Middle East & Africa By Country Sales Analysis
- 6.7.4 Saudi Arabia Sales Analysis
- 6.7.5 UAE Sales Analysis
- 6.7.6 Israel Sales Analysis
- 6.7.7 South Africa Sales Analysis
- 6.7.8 Rest Of Middle East And Africa Sales Analysis

7. COMPETITIVE LANDSCAPE OF THE HOSPITAL ACQUIRED DISEASE TESTING COMPANIES

7.1. Hospital Acquired Disease Testing Market Competition
7.2. Partnership/Collaboration/Agreement
7.3. Merger And Acquisitions
7.4. New Product Launch
7.5. Other Developments

8. COMPANY PROFILES OF HOSPITAL ACQUIRED DISEASE TESTING INDUSTRY

8.1. Top Companies Market Share Analysis
8.2. Market Concentration Rate
8.3. Abbott Laboratories
- 8.3.1 Company Overview
- 8.3.2 Company Revenue
- 8.3.3 Products
- 8.3.4 Recent Developments
8.4. Alere Inc
- 8.4.1 Company Overview
- 8.4.2 Company Revenue
- 8.4.3 Products
- 8.4.4 Recent Developments
8.5. Becton
- 8.5.1 Company Overview
- 8.5.2 Company Revenue
- 8.5.3 Products
- 8.5.4 Recent Developments
8.6. Dickinson And Company
- 8.6.1 Company Overview
- 8.6.2 Company Revenue
- 8.6.3 Products
- 8.6.4 Recent Developments
8.7. BioMeRieux SA F
- 8.7.1 Company Overview
- 8.7.2 Company Revenue
- 8.7.3 Products
- 8.7.4 Recent Developments
8.8. Hoffmann-La Roche Ltd
- 8.8.1 Company Overview
- 8.8.2 Company Revenue
- 8.8.3 Products
- 8.8.4 Recent Developments
8.9. Hologic Inc
- 8.9.1 Company Overview
- 8.9.2 Company Revenue
- 8.9.3 Products
- 8.9.4 Recent Developments
8.10. Siemens Healthcare
- 8.10.1 Company Overview
- 8.10.2 Company Revenue
- 8.10.3 Products
- 8.10.4 Recent Developments
8.11. Diatherix Laboratories Inc.
- 8.11.1 Company Overview
- 8.11.2 Company Revenue
- 8.11.3 Products
- 8.11.4 Recent Developments
8.12. Meridian Bioscience Inc.
- 8.12.1 Company Overview
- 8.12.2 Company Revenue
- 8.12.3 Products
- 8.12.4 Recent Developments
8.13. ThermFisher Scientific Inc
- 8.13.1 Company Overview
- 8.13.2 Company Revenue
- 8.13.3 Products
- 8.13.4 Recent Developments